Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study

Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study

0:00
19 January 2007

RODGER MACARTHUR, Wayne State University, Detroit REFERENCE: Lancet 2006; 368: 2125-35 A three-class HIV antiretroviral therapy is not necessary, according to data published in the Lancet. The FIRST s

Rodger MacArthur

RODGER MACARTHUR, Wayne State University, Detroit

REFERENCE: Lancet 2006;368: 2125-35A three-class HIV antiretroviral therapy is not necessary, according to data published in the Lancet. The FIRST study had three arms which included non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), or both, all in the presence of nucleoside reverse transcriptase inhibitors. Derek Thorne heard more fromRodger MacArthurof Wayne State University in Detroit.